SGLT-2 Inhibitors: The Best Best Among New T2D Drugs?

(MedPage Today) -- SGLT-2 inhibitors tied to better mortality, safety outcomes in meta-analysis
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Primary Care